Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

48

Number of overlapping holdings

37.2%

% of XBI's 129 holdings also in BMED

37.8%

% of BMED's 140 holdings also in XBI

Overlap by Weight
Sector Drift (XBI minus BMED)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XBI
Weight
in BMED
Overlap
ALNYLAM PHARMACEUTICALS INC 2.9% 2.6% 2.6%
AMGEN INC 2.8% 2.5% 2.5%
BIOMARIN PHARMACEUTICAL INC 2.7% 1.9% 1.9%
NEUROCRINE BIOSCIENCES INC 2.1% 1.3% 1.3%
BLUEPRINT MEDICINES CORP. 1.2% 1.3% 1.2%

Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to BMED
EXACT SCIENCES CORP 3.4%
GILEAD SCIENCES INC 3.0%
ABBVIE INC 2.9%
REGENERON PHARMACEUTICALS 2.9%
VIKING THERAPEUTICS, INC. 2.8%
INCYTE CORP 2.1%
UNITED THERAPEUTICS CORP 2.1%
VERTEX PHARMACEUTICALS INC 2.0%
NATERA INC 2.0%
CYTOKINETICS INC 2.0%
XBI Underweight Relative to BMED
BOSTON SCIENTIFIC CORP -3.7%
AMERISOURCEBERGEN CORP -3.4%
INTUITIVE SURGICAL INC -2.8%
ARGENX SE ADR -2.4%
METTLER-TOLEDO INTERNATIONAL -2.4%
WEST PHARMACEUTICAL SERVICES -2.3%
DANAHER CORP -2.0%
BIO-TECHNE CORPORATION -1.9%
QIAGEN NV -1.8%
MCKESSON CORP -1.7%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY